Physician profile
Deborah Jensen
NPI 1972026938
$800.76
in general payments reported to CMS, 2019-2025
16 companies · $801 in 2025
The $801 reported for 2025 was more than what 83% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $152.85 | 2025 | |
| Baxter Healthcare | $94.96 | 2025 | Hillrom - Monarch Airway Clearance System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.20 | 2025 | Jascayd, Ofev |
| Merck Sharp & Dohme LLC | $77.73 | 2025 | Winrevair |
| Verona Pharma, INC. | $68.24 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $56.75 | 2025 | Sunosi |
| Lilly USA, LLC | $39.99 | 2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $35.82 | 2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $34.74 | 2025 | Breztri, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $31.02 | 2025 | Glassia |
| Avadel Cns Pharmaceuticals, LLC | $24.91 | 2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $23.40 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $19.51 | 2025 | Opsynvi |
| 3b Medical, INC. | $16.97 | 2025 | Luna |
| Viatris Specialty LLC | $16.42 | 2025 | Yupelri |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $14.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.